Harga saham Vir Biotechnology (VIR) hari ini, pre-market & after-hours

Data

Superchart

Legend

Lebih

Cari

Vir Biotechnology, Inc.

VIR

Nasdaq

Health Technology

Biotechnology

8.80

USD

+0.11

+1.27%

Ditutup: 07-27 20:00 (UTC+0)

8.80

USD

+0.00%

Setelah jam pasar: 07-28 00:00 (UTC+0)

VIR Statistik Utama

Tinggi

9.09

Buka

8.82

Volume

1.68M

Rendah

8.77

Cierre anterior

8.69

Nilai Perdagangan

14.99M

Tertinggi 52M

11.66

Volume relatif

1.022

Amplitudo (%)

3.62%

Terendah 52M

4.16

Tingkat Perputaran

1.00%

Kap Pasar

1.46B

P/E (TTM)

P/E (Tahunan)

2.234

P/B

1.8

P/S

22.38

Laba per Saham (EPS)

-3.137

Dividen (TTM)

Imbal Hasil Dividen

0.00%

Saham beredar

168.65M

Mata uang

USD

VIR Kinerja Harga

7 hari

30 hari

90 hari

180 hari

Sejak awal tahun

1 Tahun

VIR Distribusi Arus Dana

VIR Volume Short Sale Harian

VIR Riwayat Short Interest

VIR Snapshot Saham

As of 2026-07-28, the Vir Biotechnology, Inc. (VIR) stock price today is 8.8. Based on this price, the company has a market capitalization of $1.46B, with a P/E ratio of --. On 2026-07-28, VIR traded between 8.77 and 9.09. Today’s stock price is 0.34% above the daily low and 3.19% below the daily high, placing VIR mendekati batas bawah its most recent trading range. Trading volume currently stands at 1.68M, compared with an average daily volume of 1.65M. This suggests that trading activity is kira-kira sejalan dengan level biasanya than usual. Over the past year, Vir Biotechnology, Inc. shares have traded between 4.16 and 11.66. At today’s price, VIR is 111.54% above its 52-week low and 24.53% below its 52-week high.

VIR Berita terkait

Tentang VIR

Nama Perusahaan

Vir Biotechnology, Inc.

Sektor

Health Technology

Industri

Biotechnology

Bursa

Nasdaq

Jumlah Karyawan

367

Ukuran Lot

100

Situs resmi

www.vir.bio

Mata uang

USD

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Related Stocks

VIR FAQ

1.What is the live stock price of Vir Biotechnology, Inc. (VIR) today?

3. What is the latest pre-market price of VIR?

5.How has VIR’s stock price performed recently?

7. What is the current capital flow for VIR?

9. What is the current price of NVDA stock perps?

11. What is the market capitalization of Vir Biotechnology, Inc.?

13. What is Vir Biotechnology, Inc.’s earnings per share (EPS)?

15. Does Vir Biotechnology, Inc. pay dividends?

17. How many employees does Vir Biotechnology, Inc. have?

2. What were VIR’s trading range and trading volume on the most recent trading day?

4.What is VIR’s after-hours price?

6. What are VIR’s 52-week high and 52-week low?

8. What are VIR’s short sale volume and short interest?

10. What are Vir Biotechnology, Inc.’s P/E ratio and valuation metrics?

12. What were Vir Biotechnology, Inc.’s revenue and net income in the most recent quarter?

14.What is Vir Biotechnology, Inc.’s total number of shares outstanding?

16. Which exchange is Vir Biotechnology, Inc. listed on, and what sector and industry does it belong to?

18. What risks should investors consider before investing in VIR?